Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative disease
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- AEGERA THERAPEUTICS INC
- Publication Date
- 2006-08-24
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This Application is a continuation application of U.S. application Ser. No. 09 / 974,592, filed Oct. 9, 2001 (now allowed), which is a continuation application of U.S. application Ser. No. 09 / 617,053, filed Jul. 14, 2000 (now U.S. Pat. No. 6,300,492), which is a continuation application of U.S. application Ser. No. 08 / 800,929, filed Feb. 13, 1997 (now U.S. Pat. No. 6,133,437).BACKGROUND OF THE INVENTION
[0002] The invention relates to the diagnosis and treatment of cancer.
[0003] One way by which cells die is referred to as apoptosis, or programmed cell death. Apoptosis often occurs as a normal part of the development and maintenance of health tissues. The process occurs so rapidly that it is difficult to detect. This may help to explain why the involvement of apoptosis in a wide spectrum of biological processes has only recently been recognized.
[0004] The apoptosis pathway is now known to play a critical role in embryonic development, v...